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Minireview 
Protein kinase C in insulin releasing cells 
Putative role in stimulus secretion coupling 
Received 4 June 1990 
The evidence for the involvement of protein kinase C (PKC) in insulin secretion stimulated by glucose and Ca:” -mobilizing receptor agonists has 
been reviewed. Results of phorbol ester binding to intact cells and the measurements of the proportion of PKC associated with the membrane 
after cell fractionation are presented. Glucose stimulation leads to increased phorbol ester binding without causing membrane insertion of the en- 
zyme which. however. occurs with receptor agonists. It is suggested that the rise in cytosolic Ca *+ in response to glucose favours the apposition 
of PKC to the membrane whereas intercalation of the enzyme requires p~l~~spholipase C-mediated generation of diacylgiycerol. It is possih’ie that 
this efiect of glucose on PKC, although not mvolvcd in the initiation of secretion. could explain the potentiation of insulin release observed in 
the presence of the receptor agonists. 
Protein kinase C; Insulin secretion; Glucose; Carbachol; Cazt 
1. INTRODUCTION 
The secretion of insulin is regulated by fuel stimuli, 
hormones and neurotransmitters to obtain precise con- 
trol of blood glucose homeostasis. The mode of action 
of the different secretagogues spans from the 
depolarization of the membrane (e.g. glucose), to Ca2+ 
mobilization (e.g. acetylcholine) and cyclic AMP 
generation (e.g. glucagon) [1,2]. Therefore, the B-cell 
offers a good experimental model in which the various 
signalling pathways of importance for cell activation in 
general can be reviewed. In the present short overview 
the actions of fuel stimuli and those of Ca2+-mobilizing 
receptor agonists will be discussed, because of par- 
ticular persistent controversy regarding the role of pro- 
tein kinase C (PKC). The cyctic AMP pathway, less 
controversial in nature, will not be treated here and we 
refer the reader to a recent review [2]. 
2. Ca2+-MOBILIZING RECEPTOR AGONISTS 
The neurotransmitter acetylcholine and its analogue 
carbachol bind to muscarinic receptors which, in insulin 
secreting cells, leads to the activation of phospholipase 
C (PLC) via GTP-binding protein not sensitive to per- 
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tussis toxin [I]. In this manner, as in other cells, the 
hydrolysis of phosphatidylinositol-4,5bisphospate 
(PIP)2 generates the second messengers diacylglycerol 
(DAG) and inositol-1,4,5-tripsphosphate (IP)i [3]. The 
former activates PKC [4] while the latter promotes Ca2+ 
mobilization from intracellular stores [1,3,5]. In insulin 
secreting cells the same pathway was also demonstrated 
for cholecystokinin [6], ATP acting as purinergic 
transmitter [7,8], bombesin [9] and, in the cell line 
RINmSF, vasopressin [lo]. These substances also in- 
crease Ca2+ Influx into the cell, perhaps via the IPj 
receptor as recently proposed [ 111. Furthermore, some 
of the agonists depolarize insulin secreting cells by clos- 
ing K + channels which is believed to lead to gated Ca2+ 
influx [12]. 
3. GLUCOSE AND OTHER FUEL STIMULI 
Glucose, in contrast to receptor agonists, enters the P- 
cell by facilitated diffusion via low affinity high capaci- 
ty glucose transporters 113,141 and is then metabolized 
by glycolysis and oxydised in the mitochondria [13]. 
This leads to the production of ATP, reduced pyridine 
nucleotides and other putative coupling factors thought 
to link metabolism to ion fluxes across the plasma mem- 
brane [2]. It is now well established that glucose and 
other nutrient stimuli depolarize the membrane poten- 
tial of insulin secreting cells by closing ATP-sensitive 
K+ channels [ 151. This, in turn, causes Ca” influx via 
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voltage-dependent Ca” channels mainiy of the L-type 
[ 161. Although there is general agreement on the intitial 
sequence of events in response to glucose, the exact 
nature of the coupling of metabolism to the membrane 
events is still a matter of debate. An increase of the 
ATP concentration and/or of the ATP/ADP ratio has 
retained most attention [15], but other mechanisms in- 
cluding the activation of PKC have been put forward 
[ 171. In fact, activation of PKC by phorbol esters and 
synthetic DAG stimulates insulin secretion [17-l 91. 
These agents have been shown to depolarize insulin 
secreting RINmSF cells by closing ATP-sensitive K+ 
channels therein mimicking the effect of the triose 
glyceraldehyde [ 171. The depolarizing action of car- 
bohydrates was therefore proposed to be mediated, at 
least in part, by the activation of PKC. In the following, 
work analysing the role of PKC in glucose stimulated 
insulin release will be discussed. 
4. GLUCOSE ACTIVATION OF 
PHOSPHOLIPASE C 
Many papers have demonstrated an effect of glucose 
on the turnover of inositol-containing phospholipids 
and an increased production of IP3 [2,20]. However, in 
contrast to the Ca2+-mobilizing agonists, the effect of 
glucose was small and clearly dependent on ex- 
tracellular Ca2+ [20]. Therefore PLC is not directly ac- 
tivated by glucose but rather stimulated by the increase 
in cytosolic Ca2+ secondary to Ca2+ influx. Indeed, in 
permeabilized RINmSF cells, as in other cell types, 
Ca2+ was found to enhance PLC activity as 
demonstrated by measuring both IP3 [21] and DAG (22) 
production. 
5. DE NOVO SYNTHESIS OF DAG AND ACTIVA- 
TION OF PKC 
The incubation of insulin secreting cells with stimula- 
tory concentrations of glucose generates glycolytic in- 
termediates which can be acylated to form phosphatidic 
acid and, in turn, DAG (17,23-25). Since the de novo 
synthetized DAG could stimulate PKC, the possible in- 
volvement of this enzyme was examined in the presence 
of glucose concentrations that enhance insulin secre- 
tion. Different methods have been applied. In a first at- 
tempt the effects on insulin secretion of various in- 
hibitors of the enzyme were tested. Most of them did 
not interfere with glucose stimulation [26], while some 
of them were found to inhibit the glucose response 
[27,28]. Therefore, probably because of lack of 
specificity of PKC inhibitors, this approach gave no 
unequivocal answer to the question. 
PKC is a specific receptor for phorbol esters that bind 
to and activate the enzyme [4]. Since prolonged 
pretreatment of the cells with these agents has been 
shown to down-regulate PKC [29], this property was 
used in several studies to establish the role of the en- 
zyme in the mechanism of glucose response. In such 
pretreated islets glucose still caused insulin secretion 
[26,30-331 and in one case the effect of the car- 
bohydrate was even potentiated 1321. These experiments 
are, however, not clear cut: first, a relevant amount of 
PKC activity that could account for the glucose 
stimulated insulin secretion was still detectable after 
prolonged phorbol ester treatment [31,33,34]; second, 
it is noteworthy that phorbol ester-pretreated islets not 
only preserve glucose stimulated insulin release but also 
that induced by carbachol, an agonist believed to act 
mainly via PKC activation 131,321. The latter observa- 
tion suggests that the down-regulation manoeuvre is not 
easy to interpret in intact pancreatic isiets. A role for 
PKC has been suggested from protein phosphorylation 
experiments in intact islet cells and after cell fractiona- 
tion, since some of the protein substrates were ten- 
tatively identified to be common to glucose and phorbol 
esters [35] or glucose and carbachol [33]. However, the 
effect of glucose was much less pronounced than that of 
carbachol and could not be unambigously attributed to 
PKC, since the activation of another Ca2+-dependent 
protein kinase following Ca” influx was not ruled out 
133,351. 
An alternative approach was to measure the fraction 
of PKC activity associated in a chelator stable manner 
with membranes. An increase in the amount of enzyme 
bound to the membrane has been reported in many dif- 
ferent cell types [36,37], including insulin secreting cells 
131,383, in response to Ca” mobilizing receptor 
agonists. As shown in Table I, incubation of RINmSF 
cells for 2 min in the presence of carbachol leads to an 
increase in the PKC activity recovered in the membrane 
Table I 
Effect of carbachol, olefi-acetyl-glycerol (OAG) and KC1 on 
membrane-associated protein kinase C activity in RINmSF cells 
iA) 
control 100 2 3 (5) 
carbachol 100 FM 179 I 10 (5) 
(B) 
control 100 + 7 (4) 
OAG 5 p&/ml 110 -+ 17 (4) 
OAG 50 @g/ml 144 (2) 
KC1 48 mM 103 i 7 (4) 
OAG 5 &ml+ KC1 48 mM 222 I 38 (4) 
OAG 50 agiml -t- KC1 48 mM 220 (2) 
RlNm5F cells were cultured in suspension for 3 h and then washed 
twice with modified Krebs-Ringer bicarbonate buffer [45]. The cells 
were then incubated for 2 min (A) or 5 min (B) in the presence or 
absence of the indicated stimuli. The cells were homogenized by 
sonication in a Ca*’ chelator containing buffer and the microsomal 
fraction prepared as described in detail previously 1221. PKC activity 
was measured after partial purification of the enzyme by 
polyacrylamide gel electrophoresis 1221. The results are given as % 
control and are the mean ? SE of the number of observations in- 
dicated in parentheses. 
377 
Volume 268, number 2 FEBS LETTERS July 1990 
fraction. The subcellular redistribution of PKC is con- 
sidered as an index of activation of the enzyme. Such 
redistribution was not observed when either islets 
128,391 or the insulin secreting cell line HIT 1401 were in- 
cubated in the presence of stimulatory concentrations 
of glucose. 
There are several possible e~pianatjoIls for these 
results: first, the DAG formed by de novo synthesis 
contributes only to a minor extent to the total DAG 
mass [25], and is therefore insufficient to activate the 
enzyme. Second, the DAC produced from the 
glycolytic intermediates has a different location in the 
cell (not at the plasma membrane) compared to that 
formed by PIP2 hydrolysis and can therefore not in- 
teracr with the enzyme. Third, the DAG species 
originating from de nova synthesis and the PIP2 tur- 
nover are distinct in their fatty acid conlposition [24,41] 
and have different efficacy of PKC activation 140,423. 
Thus, several studies have concluded that PKC is not in- 
volved in glucose stimulated insulin secretion. 
However, some questions still remain. It is, for in- 
stance, not known, at present, if the association of PKC 
with the membrane is an absoIute requirement for the 
activation of this enzyme. Indeed conditions can be 
found where a ceil-permeable DAG analog, I-oleyl- 
Zacetylglycerol (UAG), while causing maximal secre- 
tion, did not increase the amount of PKC associated 
with the membrane (Table I). OAG at SO &g/ml 
stimulates insulin release from 19 + 3 (mean i. SE, 
n = IO) to 39 + 4 ng/lO” c&s (n = 12) and increases the 
amount of PKC recovered in the membrane fraction. 
However, OAG at 5 Fg/mi while enhancing secretion to 
the same extent as 50 @g/ml (36 -e 3 ng/lO’” cells, 
n = 12) causes no significant changes in PKC distribu- 
tion (Table l). These results suggest that either OAG 
can affect insulin secretion without activating PKC via 
an unknown mechanism, or that PKC can be activated 
without detectable increase in the proportjori of the en- 
zyme associated with the membrane. A generally ac- 
cepted model for the activatiorl of PKC by DAG, in 
contrast to phorbol esters, proposes the formation of a 
quaternary complex between the enzyme, 
phospholipids, DAG and Ca2+ f431. Ca2* is thought to 
permit the priming of the enzyme by bringirlg it in close 
apposition to the membrane. Experimental evidence 
has confirmed this model in intact cells t36], 
permeabiiized cells [22] and red cell ghosts 1441, In 
permeabili~ed RINmSF cells endogenous DAG was 
produced by stimulating PLC with a rlorl-hydro~ysabie 
GTP analog [22]. Whiie a similar amount of DAG was 
generated at basal (10 - ’ h4) and at higher Ca”’ concen- 
trations (2 10 - 6 M), the transiocation of PKC only oc- 
curred in the presence of lo-’ M Ca*’ or higher [22]. 
A corollary of these findings is shown in Table B where 
cytosolic Ca2+ was raised by depoiarizing the cells with 
KCI [45]. KC1 alone does not promote association of 
PKC with ceHuIar membranes but permits such an 
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association to occur after stjmulatio~l with OAG. This 
is seen both under conditions where OAG is inefficient 
(5 @g/ml) and with the higher concentration (SO +g/ml) 
where OAG irself causes translocation. Tkse results 
clearly demonstrate that an increase in cy&osolic Ca” 
favours the DAG induced activation of PKC. In view of 
these findings it is conceivable that glucose, which 
raises cytosolic Car- ([Ca)““]};) both in the normal B- 
cell [46] and in HIT ceIis [40,47], primes PKC to a loca- 
tion in the proximity of the membrane. This hypothesis 
was tested by performing phorbol ester binding ex- 
periments on intact HIT cells. This approach has been 
shown to be useful for the monitoring of CaLc effects 
on PKC in astrocyton~a cells [48]. The results of ex- 
periments in which [~Ii]p~lorbol dibiltyratc (PDBU) 
binding was measured after short exposure of insulin 
secreting HIT cells to the secretagogues glucose, 
bombesin and KC1 are illustrated in Fig. I. Glucose, like 
KC?, raises [Ca”“fi by depolarizing the ceils and pro- 
moting Ca ‘+ influx without generating sizeble amounts 
of DAG in the plasma membrane [25,40]. The [Ca”+]i 
elevation in the absence of increased DAG production 
provides an increased number of PDBU binding sites 
on ll~embrane-associated PKC. Bombesin stimulation 
also causes a [Ca“)i rise 191, but simLlltaneously 
generates DAG in the plasma membrane 19,401 which 
competes with PDBU for binding to PKC. This would 
explain why bomb&n, in contrast to KC1 and gIucose, 
does not augment the PDBU binding (Fig. 1). This con- 
clusion agrees with the findings of Trilivas and Brown, 
who observed that carbachol stimulated PDBU binding 
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Fig. I. Effect of &cosc, bomb&n and KC1 on phorbol ehter binding 
to intact HIT cells, HIT-TtS cells 140,471 were incubated for 3 h in 
q%nner culture. washed twice in a modified Krebs-Ringer bicarbonate 
buffer [45J without glucose and preincubated in the same buffer at a 
concentration of about 1 x 10” celfs:ml for 30 min. 20 t&l [‘HI- 
phorhol dibutyrare (0.8 pCi/ml) was then added and the cells in- 
cubated for 10 min at 3X’. The stimuli were pl-esrnt during the last 
minutes of incubation (I min for bomhesin and KCI; 3 min for 
glucose). The ceil suqensions were transferred to GFIC microfibre 
filterr and the latter rinsed J-fold with ice-cold tire&-Ringer buffer 
without glucose before counting. The results are expressed as B of 
control and are the mean t SE of tao independent esperimentb per- 
formed in triplicate. P < 0.05 for ail conditions except for bombcsin 
alone. 
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time when the muscarinic agonist increased the produc- 
tion of DAC [48]. Another method for the demonstra- 
tion of PKC redistribution involves the localization of 
the enzyme by inln~unocytochemistry. Using this 
method, in leukemic cells the Ca’+ ionophore 
ionomycin induced the membrane association of PKC 
1491. This association was not chelator-St able as assess- 
ed after cell fractionation [49f. ‘Thus these findings with 
ionomycin involving the two approaches are similar to 
our results with glucose and KC1 examining PDBU bin- 
ding and chelator-stable membrane association of 
PKC. 
CARBACHOL 
,Jq_ _ _ 
6. POTENTIAL ROLE FOR PKC IN INSULIN 
SECRETION 
In insulin secreting cells, as in other cell types, PKC 
appears to undergo activation in two stages. Under 
resting conditions the enzyme is cytosolic or only loose- 
ly attached to the plasma membrane. An increase in 
[Ca’+]i converts the enzyme to a preactivated, prime 
state by association with the membrane (round symbol 
in Fig. 2). This stage can only be detected in intact cells 
(phorbol ester binding or immunohistochemistry) since 
the membrane association does not withstand subcel- 
lular fractionation in the presence of cation chelators. 
The third, membrane-intercalated stage of the enzyme 
requires increased production of DAG in the mem- 
brane. This chelator stable membrane association is 
observed when the cells are stimulated with Ca2+ 
mobilizing agonists such as carbachol and bombesin 
which stimulate DAG production from membrane 
phospholipids (Fig. 2, upper panel) [24,40,41]. In con- 
trast, glucose and other fuel stimuli only generate small 
amounts of DAG in the plasma membrane following 
the limited activation of PLC secondary to the [Ca2+]i 
rise [20] (not included in Fig. 2). Therefore, glucose is 
not expected to cause significant intercalation of PKC 
into the membrane agreeing with the experimental 
observations [28,39,40]. However, glucose and 
depolarizing concentrations of KC1 appear to favour 
Ca2+-mediated membrane association of the enzyme 
(Fig. 2, lower panel). In this case, the [Ca”‘]i rise is due 
to Ca2+ influx through voltage-gated channels. These 
channels are gated following the closure of ATP- 
sensitive Kt channels by glucose, other carbohydrates 
and amino acids [ 151. 
i 
Fig. 2. Proposed mechanisms by which receptor agonists and fuel 
secretagogues affect protein kinase C insuiin secretion. Protein kinase 
(PKC) undergoes a Caz*-dependent shift to the plasma membrane. 
Membrane intercalation of the enzyme requires an increase of the 
concentration of diacyiglycerol (DAG) in the plasma membrane. A, 
agonist; R, receptor; G,, p hospholipase C (PLC) activating G- 
protein; PIPa, phosphatidyl inosirol-4,5_biphosphate; IP3, inositol- 
secretion 121. The synergistic action of glucose and 
muscarinic agonists, for example, could, at least in 
part, be due to the CaZt -mediated membrane apposi- 
tion of PKC after membrane depolarization. Thus, 
despite extensive work, the detailed analysis of the 
nature of the involvement of PKC in insulin secretion 
remains to be established and probably requires new ap- 
proaches. 
In summary, it is most unlikely that PKC plays a ma- 
jor role in mediating the action of glucose and other 
fuel stimuli on insulin secretion. At present other 
Ca2+-sensitive enzymes, including protein kinases and 
phosphoprotein phosphatases, as well as other coupling 
facors such as acyl-CoA derivatives [50] are more likely 
to initiate the secretion. The main function attributed to 
PKC is the mediation of part or all of the effects of 
Ca2+ mobilizing hormones and neurotransmitters 
which are known to potentiate fuel-induced insulin 
~~c~~ow~e~~e~?enl~: This work was supported by Grant 32.25665.88 
from the Swiss National Science Foundation. 
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